Priority Date: 15.04.10 (US 20100324658P)

POTENTIATION OF ANTI-CANCER ACTIVITY THROUGH COMBINATION THERAPY WITH BER PATHWAY INHIBITORS

  • Application ID: EP11769710
  • Status: PATENT GRANTED

Attorney

no operation time available
1106.71
Headquarter in Cambridge and 3 offices
active in Legal Services

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and G01 (MEASURING; TESTING). Avidity IP Ltd is specialized in the combination A61 and G01. We found, that Coller IP Management Ltd, TransMIT GmbH, Kailuweit & Uhlemann, Bock Bieber Donath, Engel Patentanwaltskanzlei and 171 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 15.04.2010 - Priority Date (US 20100324658P)
  • 20.10.2011 - Publication A1 (WO2011130689)
  • 20.02.2013 - Publication A1 (EP2558866)
  • 17.08.2016 - Publication B1 (EP2558866)